InvestSMART

TrivarX Ltd (ASX: TRI) - Announcements

- Current share price for TRI : $0.011

ASX company news and announcements for TrivarX Ltd (TRI) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All TrivarX Ltd (TRI) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than TrivarX Ltd (TRI), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for TrivarX Ltd (TRI)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$13 Proposed issue of securities - TRI 10 Jun 2025 8:38AM $0.010 $0.011 risen by 10%
$13 Site activation for trial at West LA VA Medical Center 30 May 2025 8:23AM $0.010 $0.011 risen by 10%
$13 Notification regarding unquoted securities - TRI 20 May 2025 2:24PM $0.012 $0.011 fallen by 8.33%
$13 Cleansing Notice 20 May 2025 9:46AM $0.012 $0.011 fallen by 8.33%
$13 Application for quotation of securities - TRI 20 May 2025 9:41AM $0.012 $0.011 fallen by 8.33%
$13 Results of General Meeting 13 May 2025 11:22AM $0.013 $0.011 fallen by 15.38%
$13 Pilot Agreement - Major League Baseball affiliated Academy 7 May 2025 8:21AM $0.015 $0.011 fallen by 24.14%
$13 Notification regarding unquoted securities - TRI 7 May 2025 8:21AM $0.015 $0.011 fallen by 24.14%
$13 March 2025 Quarterly Activities Report and Appendix 4C 30 Apr 2025 11:29AM $0.013 $0.011 fallen by 15.38%
$13 IRB approval for trial with US Dept of Veterans Affairs 28 Apr 2025 8:31AM $0.012 $0.011 fallen by 8.33%
$13 Letter to Shareholders & Notice of GM & Proxy Form 3 Apr 2025 11:14AM $0.013 $0.011 fallen by 15.38%
$13 Change in substantial holding 26 Mar 2025 6:41PM $0.013 $0.011 fallen by 15.38%
$13 Cleansing Notice 26 Mar 2025 10:16AM $0.014 $0.011 fallen by 21.43%
$13 Application for quotation of securities - TRI 26 Mar 2025 10:15AM $0.014 $0.011 fallen by 21.43%
$13 Proposed issue of securities - TRI 25 Mar 2025 2:22PM $0.013 $0.011 fallen by 12%
$13 Cleansing Notice 24 Mar 2025 10:23AM $0.012 $0.011 fallen by 8.33%
$13 Application for quotation of securities - TRI 24 Mar 2025 10:22AM $0.012 $0.011 fallen by 8.33%
$13 Proposed issue of securities - TRI 17 Mar 2025 9:26AM $0.015 $0.011 fallen by 26.67%
$13 Proposed issue of securities - TRI 17 Mar 2025 9:26AM $0.015 $0.011 fallen by 26.67%
$13 TrivarX Receives Firm Commitments to Raise $2.25 million 17 Mar 2025 9:25AM $0.015 $0.011 fallen by 26.67%
$13 Trading Halt 13 Mar 2025 8:52AM $0.015 $0.011 fallen by 26.67%
$13 Trial with US Department of Veterans Affairs 13 Mar 2025 8:34AM $0.015 $0.011 fallen by 26.67%
$13 Appendix 4D & Half-Year Financial Report to 31 December 2024 28 Feb 2025 3:11PM $0.016 $0.011 fallen by 31.25%
$13 December 2024 Quarterly Activities Report and Appendix 4C 31 Jan 2025 8:19AM $0.018 $0.011 fallen by 38.89%
$13 Positive engagement with FDA following meeting for MEB-001 28 Jan 2025 11:16AM $0.017 $0.011 fallen by 35.29%

76 - 100 of 210 results

Page 4 of 9

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.